MedPath

寿光富康制药有限公司

Ownership
-
Established
1997-07-08
Employees
-
Market Cap
-
Website
www.fukangpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

NMPA:20

Drug Approvals

Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets

Product Name
吡格列酮二甲双胍片
Approval Number
国药准字H20253648
Approval Date
Mar 18, 2025
NMPA

Pantoprazole Sodium Enteric-Coated Tablets

Product Name
泮托拉唑钠肠溶片
Approval Number
国药准字H20243627
Approval Date
Apr 30, 2024
NMPA

Trospium Chloride Capsules

Product Name
曲司氯铵胶囊
Approval Number
国药准字H20140031
Approval Date
Feb 7, 2024
NMPA

Trospium Chloride

Product Name
曲司氯铵
Approval Number
国药准字H20140030
Approval Date
Feb 7, 2024
NMPA

Itraconazole

Product Name
伊曲康唑
Approval Number
国药准字H20073902
Approval Date
Oct 24, 2023
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20234145
Approval Date
Sep 12, 2023
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H20234033
Approval Date
Aug 8, 2023
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H20184067
Approval Date
May 14, 2023
NMPA

Metformin Hydrochloride Extended-release Tablets

Product Name
盐酸二甲双胍缓释片
Approval Number
国药准字H20223796
Approval Date
Nov 1, 2022
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20227136
Approval Date
Oct 18, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.